Neutrophil-to-Lymphocyte Ratio Is a Prognostic Marker in Acute Ischemic Stroke

Journal of Stroke and Cerebrovascular Diseases

Volumn 26, Issue 3, 2017, Pages 650-657

  Xue, Jie ^a   Huang, Wensi ^a   Chen, Xiaoli ^a   Li, Qian ^a   Cai, Zhengyi ^a   Yu, Tieer ^a   Shao, Bei ^a  

^a THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

acute ischemic stroke; inflammation; Neutrophil to lymphocyte ratio; prognosis

Indexed keywords

C REACTIVE PROTEIN; CREATININE; DRUG; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; CHOLESTEROL; GLUCOSE BLOOD LEVEL; LIPOPROTEIN;

ADULT; ARTICLE; ATRIAL FIBRILLATION; BARTHEL INDEX; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONFOUNDING VARIABLE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; DRINKING BEHAVIOR; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUTROPHIL LYMPHOCYTE RATIO; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROGNOSTIC ASSESSMENT; PROTEIN BLOOD LEVEL; RANKIN SCALE; RECURRENT DISEASE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SMOKING; SYSTOLIC BLOOD PRESSURE; TELEPHONE INTERVIEW; AGED; BLOOD; COMPLICATION; DIET RESTRICTION; ELECTROCARDIOGRAPHY; LYMPHOCYTE; METABOLISM; NEUTROPHIL; NUCLEAR MAGNETIC RESONANCE IMAGING; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STROKE;

AGED; BLOOD GLUCOSE; BRAIN ISCHEMIA; C-REACTIVE PROTEIN; CHOLESTEROL; ELECTROCARDIOGRAPHY; FASTING; FEMALE; HUMANS; LIPOPROTEINS; LYMPHOCYTES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUTROPHILS; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 85008235141     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2016.11.010     Document Type: Article

References (43)

1. 1 Sacco, R.L., Kasner, S.E., Broderick, J.P., et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44 (2013), 2064–2089.
2. 2 Liu, L., Wang, D., Wong, K.S., et al. Stroke and stroke care in China: huge burden, significant workload, and a national priority. Stroke 42 (2011), 3651–3654.
3. 3 Allen, C.L., Bayraktutan, U., Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int J Stroke 4 (2009), 461–470.
4. 4 Chamorro, A., Hallenbeck, J., The harms and benefits of inflammatory and immune responses in vascular disease. Stroke 37 (2006), 291–293.
5. 5 Worthmann, H., Tryc, A.B., Deb, M., et al. Linking infection and inflammation in acute ischemic stroke. Ann N Y Acad Sci 1207 (2010), 116–122.
6. 6 McColl, B.W., Allan, S.M., Rothwell, N.J., Systemic infection, inflammation and acute ischemic stroke. Neuroscience 158 (2009), 1049–1061.
7. 7 Rodrigues, S.F., Granger, D.N., Leukocyte-mediated tissue injury in ischemic stroke. Curr Med Chem 21 (2014), 2130–2137.
8. 8 Buck, B.H., Liebeskind, D.S., Saver, J.L., et al. Early neutrophilia is associated with volume of ischemic tissue in acute stroke. Stroke 39 (2008), 355–360.
9. 9 Grau, A.J., Boddy, A.W., Dukovic, D.A., et al. Leukocyte count as an independent predictor of recurrent ischemic events. Stroke 35 (2004), 1147–1152.
10. 10 Kim, J., Song, T.J., Park, J.H., et al. Different prognostic value of white blood cell subtypes in patients with acute cerebral infarction. Atherosclerosis 222 (2012), 464–467.
11. 11 Furlan, J.C., Vergouwen, M.D., Fang, J., et al. White blood cell count is an independent predictor of outcomes after acute ischaemic stroke. Eur J Neurol 21 (2014), 215–222.
12. 12 Imtiaz, F., Shafique, K., Mirza, S.S., et al. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int Arch Med, 5, 2012, 2.
13. 13 Walsh, S.R., Cook, E.J., Goulder, F., et al. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 91 (2005), 181–184.
14. 14 Tamhane, U.U., Aneja, S., Montgomery, D., et al. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol 102 (2008), 653–657.
15. 15 Arbel, Y., Finkelstein, A., Halkin, A., et al. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography. Atherosclerosis 225 (2012), 456–460.
16. 16 Bhat, T., Teli, S., Rijal, J., et al. Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev Cardiovasc Ther 11 (2013), 55–59.
17. 17 Tokgoz, S., Kayrak, M., Akpinar, Z., et al. Neutrophil lymphocyte ratio as a predictor of stroke. J Stroke Cerebrovasc Dis 22 (2013), 1169–1174.
18. 18 Celikbilek, A., Ismailogullari, S., Zararsiz, G., Neutrophil to lymphocyte ratio predicts poor prognosis in ischemic cerebrovascular disease. J Clin Lab Anal 28 (2014), 27–31.
19. 19 Stroke—1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders. Stroke 20 (1989), 1407–1431.
20. 20 Adams, H.P., Bendixen, B.H., Kappelle, L.J., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24 (1993), 35–41.
21. 21 Sims, J.R., Gharai, L.R., Schaefer, P.W., et al. ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes. Neurology 72 (2009), 2104–2110.
22. 22 Adams, H.P. Jr, del Zoppo, G., Alberts, M.J., et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 115 (2007), e478–e534.
23. 23 Brott, T., Adams, H.P., Olinger, C.P., et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20 (1989), 864–870.
24. 24 Ducroquet, A., Leys, D., Al Saabi, A., et al. Influence of chronic ethanol consumption on the neurological severity in patients with acute cerebral ischemia. Stroke 44 (2013), 2324–2326.
25. 25 van Swieten, J.C., Koudstaal, P.J., Visser, M.C., et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19 (1988), 604–607.
26. 26 Mahoney, F.I., Barthel, D.W., Functional evaluation: the Barthel index. Md State Med J 14 (1965), 61–65.
27. 27 Emsley, H.C., Smith, C.J., Gavin, C.M., et al. An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J Neuroimmunol 139 (2003), 93–101.
28. 28 Yoon, S.S., Zheng, Z.J., Elevated total white blood cell count with high blood glucose is associated with poor outcome after ischemic stroke. J Stroke Cerebrovasc Dis 14 (2005), 88–93.
29. 29 Kleinig, T.J., Vink, R., Suppression of inflammation in ischemic and hemorrhagic stroke: therapeutic options. Curr Opin Neurol 22 (2009), 294–301.
30. 30 Hartl, R., Schurer, L., Schmid-Schonbein, G.W., et al. Experimental antileukocyte interventions in cerebral ischemia. J Cereb Blood Flow Metab 16 (1996), 1108–1119.
31. 31 Frangogiannis, N.G., Smith, C.W., Entman, M.L., The inflammatory response in myocardial infarction. Cardiovasc Res 53 (2002), 31–47.
32. 32 Li, G.Z., Zhong, D., Yang, L.M., et al. Expression of interleukin-17 in ischemic brain tissue. Scand J Immunol 62 (2005), 481–486.
33. 33 Schwartz, M., Moalem, G., Beneficial immune activity after CNS injury: prospects for vaccination. J Neuroimmunol 113 (2001), 185–192.
34. 34 Kim, J.Y., Kawabori, M., Yenari, M.A., Innate inflammatory responses in stroke: mechanisms and potential therapeutic targets. Curr Med Chem 21 (2014), 2076–2097.
35. 35 Azab, B., Zaher, M., Weiserbs, K.F., et al. Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction. Am J Cardiol 106 (2010), 470–476.
36. 36 Gokhan, S., Ozhasenekler, A., Mansur Durgun, H., et al. Neutrophil lymphocyte ratios in stroke subtypes and transient ischemic attack. Eur Rev Med Pharmacol Sci 17 (2013), 653–657.
37. 37 Tokgoz, S., Keskin, S., Kayrak, M., et al. Is neutrophil/lymphocyte ratio predict to short-term mortality in acute cerebral infarct independently from infarct volume?. J Stroke Cerebrovasc Dis 23 (2014), 2163–2168.
38. 38 Köklü, E., Yüksel, İ., Arslan, Ş., et al. Is elevated neutrophil-to-lymphocyte ratio a predictor of stroke in patients with intermediate carotid artery stenosis?. J Stroke Cerebrovasc Dis 25 (2016), 578–584.
39. 39 Hyun, S., Kwon, S., Cho, S., et al. Can the neutrophil-to-lymphocyte ratio appropriately predict carotid artery stenosis in patients with ischemic stroke? A retrospective study. J Stroke Cerebrovasc Dis 24 (2015), 2646–2651.
40. 40 Grogaard, B., Schurer, L., Gerdin, B., et al. Delayed hypoperfusion after incomplete forebrain ischemia in the rat. The role of polymorphonuclear leukocytes. J Cereb Blood Flow Metab 9 (1989), 500–505.
41. 41 Easton, A.S., Neutrophils and stroke—can neutrophils mitigate disease in the central nervous system?. Int Immunopharmacol 17 (2013), 1218–1225.
42. 42 Krams, M., Lees, K.R., Hacke, W., et al. Acute Stroke Therapy by Inhibition of Neutrophils (ASTIN): an adaptive dose-response study of UK-279,276 in acute ischemic stroke. Stroke 34 (2003), 2543–2548.
43. 43 Spite, M., Serhan, C.N., Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins. Circ Res 107 (2010), 1170–1184.